Product: Levothyroxine Sodium Tablets USP, 175 mcg, packaged in a) 90-count bottles (NDC 0378-1817-77) and b) 1000-count bottles (NDC 0378-1817-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.
Reason for recall: Superpotent Drug and Subpotent Drug: potency failures obtained
Recall initiated: 20241118
Status: Ongoing
Classification: Class II
Recall type: Voluntary: Firm initiated